APA (7th ed.) Citation

Ezekowitz, M. D., & Brückmann, M. (2016). Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation. Europace, 18(7), . https://doi.org/10.1093/europace/euv312

Chicago Style (17th ed.) Citation

Ezekowitz, Michael D., and Martina Brückmann. "Long-term Evaluation of Dabigatran 150 Vs. 110 Mg Twice a Day in Patients with Non-valvular Atrial Fibrillation." Europace 18, no. 7 (2016). https://doi.org/10.1093/europace/euv312.

MLA (9th ed.) Citation

Ezekowitz, Michael D., and Martina Brückmann. "Long-term Evaluation of Dabigatran 150 Vs. 110 Mg Twice a Day in Patients with Non-valvular Atrial Fibrillation." Europace, vol. 18, no. 7, 2016, https://doi.org/10.1093/europace/euv312.